Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.

Heart Failure With Preserved Ejection Fraction Clinical Trial

Official title:

Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05822622
• Other study ID #: Soh-Med-23-02-03
• Status: Not yet recruiting
• Start date: April 29, 2023
• Est. completion date: August 30, 2023

Study information

• Verified date: April 2023
• Source: Sohag University
• Contact: Asmaa E khalifa, resident
• Phone: 01021344185
• Email: asmaaelsayed[@]med.sohag.edu.eg
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The aim of our study to determine the demography, relation between patients with heart failure with preserved ejection fraction and those with nonalcoholic fatty liver disease in Sohag university hospital.

Description:

type of the study cross sectional study to study the relationship between heart failure with preserved ejection fraction and nonalcoholic fatty liver disease.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: August 30, 2023
• Est. primary completion date: July 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria: clinical diagnosis of heart failure with preserved ejection fraction. clinical diagnosis of nonalcoholic fatty liver disease. - Exclusion Criteria: rheumatic heart disease ,congenital heart disease , ischemic heart disease ,heart failure with reduced ejection fraction , hepatitis B virus , hepatitis C virus . -

Related Conditions & MeSH terms

• Fatty Liver
• Heart Failure
• Heart Failure With Preserved Ejection Fraction
• Liver Diseases
• Non Alcoholic Fatty Liver
• Non-alcoholic Fatty Liver Disease

Intervention

Other:
• echocardiography
to determine finding of heart failure with preserved ejection fraction and non alcoholic fatty liver disease

Locations

Country	Name	City	State
Egypt	Asmaa E khalifa	Sohag
Egypt	Asmaa elsayed khalifa	Sohag	El Monshah

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017 Apr;3(1):7-11. doi: 10.15420/cfr.2016:25:2. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	collection of results of echocardiography (those detect HFpEF) with abdominal ultrasound and transient elastography results (those detect NAFLD) and find relationship between the results.	looking for relationship between echocardiographic findings (that detect heart failure with preserved ejection fraction) and finding in abdominal ultrasound and transient elastography (detection of nonalcoholic fatty liver disease) to detect the relationship between those two diseases.	up to 28 weeks.